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Abstract
Mycoplasma genitalium is a sexually-transmitted bacterial pathogen that persists in
patients by adherence to cells through matrix glycoproteins and evasion of host antibodies.
The MgpB and MgpC adherence proteins consist of variable and conserved regions.
Variable regions undergo antigenic variation to avoid specific antibodies. However, the Cterminus (MgpB-4a) does not vary, is highly immunogenic, and antibodies to this region
inhibit attachment and promote bacterial killing in vitro. To better understand how M.
genitalium avoids clearance by antibodies to MgpB-4a in vivo we used surface plasmon
resonance (SPR) to measure kinetic values of binding events. Binding of polyclonal rabbit
antibodies (3935 and 3936) raised against MgpB-4a was measured against recombinant
protein fragments truncated at the N- and C-termini. The two antibody sera produced by
two separate, identical inoculations exhibit different kinetics and thermodynamics of
binding while binding tightly and specifically to fragments of the mycoplasma adhesin
domain MgpB-4a. Antibodies from both rabbits bound tightly to MgpB-4a fragments with
dissociation constants of 10 nM-1 pM. A higher temperature (37°C) reduced binding of
fragments to both antibodies, affecting 3936 more than 3935. Each antibody exhibits
different kinetic signatures, with 3935 binding more tightly to smaller protein fragments
and 3936 binding more tightly to larger fragments. Both antibodies bind tightly and with
similar dissociation rates too slow to measure, differing most in on-rates. The 3935 and
3936 antibodies are specific to the MgpB-4a domain, as other antibodies raised against
MgpB-B bind to the same fragments at higher dissociation constants of 1 μM. Future
experiments will compare these binding signatures to those of patient antibodies to explain
how antibodies are avoided in vivo.
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Introduction
Mycoplasma genitalium (Mg) is a sexually transmitted bacterial pathogen that
causes a multitude of symptoms such as cervicitis in women and non-gonococcal
urethritis in men (Wiesenfeld and Manhart). Mg infection can persist for months to years,
and infection by Mg increases susceptibility to sexually transmitted infections such as
HIV; Mg binding decreases the integrity of endocervical cells, increasing the passage of
pathogens through epithelial barriers and causing infection (Vandepitte et al.) Mg
infection affects between 1-3% of the US population and is primarily treated with
Azithromycin and Doxycycline (Sliferski et al.; Bradshaw et al.). Alarmingly, multidrug
resistance frequency is increasing, and previous treatment methods are becoming
ineffective for patients leading to the necessity for the development of novel clinical
treatments (Bradshaw et al.). These new therapies are aimed at replacing traditional
antibiotics through identifying ways in which the bacteria persist in the body despite an
immune response.
Mg is able to evade the immune response by adherence to matrix glycoproteins,
and through antigenic variation of epitopes. Epitopes are regions of an antigen molecule
where an antibody binds, while matrix glycoproteins are extracellular macromolecules to
which Mg binds, allowing it to persist in the body. The antibodies developed in a typical
immune response to infection are raised primarily against the MgpB and MgpC adhesin
proteins (McGowin and Totten). MgpB and MgpC are two proteins that allow Mg to
adhere to endothelial cells. Using sub-tomogram averaging, previous research shows
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these two proteins form a dimer complex consisting of 4
lobes total in an extracellular domain* (Figure 1). These
adhesin proteins are necessary for virulence, and
sequencing of the MgpB and MgpC adhesin proteins reveal
they consist of variable and conserved regions across
bacterial samples. Specifically, a region within the Cterminus of MgpB (recombinant protein MgpB-4a) does
not vary and is highly immunogenic, located near the

Figure 1: Sub-tomogram
average of MgpB/C adhesin
complex. (Scheffer et al)

transmembrane domain of the protein (Figure 2). Antibodies to this region inhibit
attachment and promote bacterial killing in vitro (McGowen and Totten). Previous
research on MgpB-4a has shown this region binds to fibronectin and plasminogen at
different sites, suggesting this region consists of multiple binding sites for optimized cell
adhesion (Mahlum et al.).

Figure 2: Representational graph of MgpB protein showing the location of the
recombinant protein MgpB-4a relative to entire sequence. (Iverson-Cabral et al.)
To better understand how M. genitalium avoids clearance to MgpB-4a in vivo we
used surface plasmon resonance (SPR) to measure kinetic and thermodynamic values of
binding events to establish epitopes on the adhesin protein Mgp-4a. Knowledge of these
binding sites can explain how antibodies are failing to bind sites that would result in
clearance, and help us determine where they may be binding instead. Previous research
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established SPR can be successfully used to measure binding affinities of antibodies to
recombinant proteins (Mahlum et al.). SPR uses a light source aimed at a chip with bound
protein, and this light is reflected off at a certain angle. When a protein is bound to a chip
and an analyte in solution flows over, the analyte will then bind to the protein on the chip,
and the total mass bound to the
chip will increase. This results in
a change in the refractive index
(Figure 3). These changes in
angles allow us to measure Kd,
and on/off-rates of binding. A

Figure 3: Surface Plasmon Resonance (SPR) higher on-rate suggests little energy
SPR measures changes in resonance angle in real time. This
change is directly related to the amount of protein near the is required for binding, but a higher
surface of the chip through the change in refractive index.
(Sabban, 2011)

off-rate suggests the interaction

formed is weak and dissociates quickly. The Kd relates these two values into a single
𝑘

constant, where Kd = 𝑘 𝑜𝑛 , so it is important to note equal Kd values can have differences
𝑜𝑓𝑓

in on and off rates, signifying different kinetics of binding despite a similar K d. Overall,
a lower Kd suggests a smaller concentration of antibody is necessary to bind antigen and
the antibody has high affinity for the antigen, with the opposite true for a higher Kd.
Using either the recombinant proteins or polyclonal antibodies as analytes or ligands, we
are able to measure the binding signatures of their interactions in real time.
The purpose of this study is to evaluate the varying kinetic signatures of two
polyclonal rabbit antibodies to explain how antibodies are avoided in vivo. Kinetic
signatures involve on-rates, off-rates, and Kd binding constants: how quickly the
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antibodies bind, how quickly they dissociate, and how much they bind overall. Using
SPR, we are able to measure these different kinetic signatures and obtain 3 values for the
binding events observed. Understanding the epitopes and kinetic signatures of these
polyclonal antibodies will tell us how the immune system targets this bacterium and why
it is failing to clear the infection. Future work focused on patient antibodies and how M.
genitalium avoids clearance in vivo can help with the development of targeted therapies
that can hinder bacterial adhesion or assist in a directed immune response.
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Materials and Methods
Protein and Antibody Production and Purification (Aguila et. al.)
MgpB-4a truncations and mutations were cloned into a pET plasmid vector. Proteins
were expressed in BL21 alpha E. coli competent cells and were purified using nickel
affinity chromatography. Using a BCA assay, purified protein concentrations were
quantified. Rabbits were immunized with recombinant protein 4a (Figure 2). Serum was
subsequently collected, and antibodies were purified using affinity-based purification
kits.
Surface Plasmon Resonance (SPR) Data Collection
All reactions were completed at 25 oC unless otherwise stated. BIACORE X machine
collected data in real time using BIACORE X Control Software. HBSEP buffer was used
as solvent in all solutions unless otherwise stated. HBSEP was taken up by inlet tube
during all CM5 chip data acquisition. FC1 was set as the blank, with no protein or
antibody bound while FC2 was used as protein-bound channel.
Determining Preconcentration
The pH of solution can change the overall charge on a protein to allow for a positive
protein to bind to the negatively charged surface of the chip. Different pH values can
create a charged protein, and the best pH value was determined before each coupling to
ensure chip would bind protein properly. Run settings set as: Multichannel, >10μL/min
rate with reference cell=1. A blank CM5 chip was docked in the machine, with different
pH conditions injected into the loop to determine optimum pH for coupling. Different pH
conditions of sodium acetate buffer (pH=4.05, 4.51, 5.08, and 5.49) with a 1:10 dilution
of protein to pH were injected. Regeneration in-between samples was done with 50 mM
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NaOH. Best pH conditions were selected looking for highest response difference in flow
channel 2.
Collecting Preliminary Antibody/Protein Data
Highest concentration in data acquisition of antibodies/protein with a coupled chip was
determined through the use of serial dilutions ranging from 1:10-1:3000 with HBSEP. A
response difference of ~100 was optimal for the high concentrations, as this difference
suggests a detectable amount of analyte bound to chip without saturating binding sites.
This is then used in a two-fold dilution series down to 1/32 of the high concentration.
Regeneration of Surface Using NaOH
Different concentrations of NaOH (ranging from 10-50 mM) was used to regenerate
surface and interrupt protein-antibody binding. Regeneration allows for chip to remove
any analyte not removed during wash procedure and frees up binding sites on the bound
protein without unfolding the protein irreparably.
Basic Data Acquisition
Data acquisition was done using multichannel, 40μl/min with reference cell=1. Analyte
injections during data acquisition done by injecting liquid followed by air-bubbles to
avoid diluting the analyte with buffer. A blank of HBSEP, no delay, was injected into the
loop. This was then repeated with a 180 second wash delay blank injection. Analytes
were then injected from 1/32 dilution to high concentration with a 180 second wash
delay. Regeneration was used as needed and repeats were completed if baselines drifted
during data acquisition or bubbles interrupted analysis of binding events. 3 separate runs
of data acquisition were performed per analyte.
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Surface Plasmon Resonance (SPR) Data Processing
Data processing of antibody-protein binding curves was completed on BIAevaluation
software. Equilibrium data and kinetic data were analyzed per individual run. For kinetic
data, blank was subtracted from all analyte concentrations. Kinetics were fit with
association and dissociation 1:1 Langmuir binding model. Kinetics were fit either
simultaneously or separately (during antibody on chip experiments). Using triplicate data
sets, average kon and koff values were determined, with most averages less than 20%.
Errors (SE) were determined by incorporating magnitude of error with the measured
values in accordance to previous research (McFarland). Dissociation time was
determined by the wash delay (180 seconds). For samples that did not dissociate
detectably within the set time period, a minimum rate constant of 10-5 s-1 was set. Beyond
this limit, off-rates are likely not biologically relevant.
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Results and Discussion
The Mgpb-4a domain is 168 amino acids long and consists of multiple charged
amino acids thought to be involved with antibody binding. Using their previous
experience with microbiology and immunology, our collaborators identified these amino
acids of interest and truncations/point mutations were designed that could aid in
identifying binding sites. SUMO-tagged MgB-4a recombinant proteins with domain
truncations at the N- and C-termini or introduction of point mutations at key arginine
residues (Figure 4) were bound to polyclonal anti-MgpB-4a antibodies produced in two
rabbits. Antibodies from both rabbits bound tightly to these recombinant proteins with
EGLKEETSIQAETLKKFFDSKQNNKSEIGIGDSTFTKMDGKLTGVVSTPLVNLINGQGA
TSDSDTEKISFKPGNQIDFNRLFTLPVTELFDPNTMFVYDQYVPLLVNLPSGFDQASIR
LKVISYSVENQTLGVRLEFKDPQTQQFIPVLNASSTGPQTVFQPFNQWAD

Figure 4: MgpB-4a sequence, truncations, and mutations
Recombinant proteins 3-5, with truncated N, C, or both termini, shown above with respective
length and size relative to fragment 1 (full 4a domain sequence without transmembrane region).
N and C terminals highlighted in MgpB-4a sequence above truncation representation. 2a-c point
mutations, Arginine to Alanine point mutations, are underlined/bolded in the sequence above.
SUMO tags include one His tag at N-terminus.
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dissociation constants in the nanomolar to picomolar range (Figure 5). Antibodies from
rabbits immunized with a different domain of the MgpB adhesin protein (MgpB-B)
bound MgpB-4a fragments with weak binding constants in the micromolar range or
weaker, suggesting the two rabbit antibodies explored here exhibit specific binding to
these SUMO MgB-4a constructs. SUMO tags were used for purification as previous data
suggests using multiple His tags increases non-specific binding to antibody sera (Mahlum
et al.).

Figure 5: 3936 and 3935 antibodies bind tightly to antigen, but with
different kinetic signatures
Kon/Koff plot for the 3936 and 3935 kinetic signatures measured via SPR and evaluated on
BIAeval. Orange arrow shows differences of binding patterns at 37C for fragment 3. Blue
arrows show differences in binding of 3936 between truncations, binding more tightly to larger
recombinant proteins. 3936 binds most tightly to fragment 1 at close to 1pM. Yellow arrows
shows difference in binding of 3935 between truncations, binding more tightly to the smaller
protein fragments. 3935 binds most tightly to fragment 3 (N terminal deletion) at close to 5 pM.

12

The polyclonal rabbit antibodies responded differently to the truncated
recombinant protein, the 2a, 2b, and 2c Arg-to-Ala mutation, and increased temperature
(Figure 5). For both antibodies, a higher temperature reduced on-rates and off-rates were
unaffected within detection limits.
For 3936, temperature and truncation decreased on-rates meaning there are
multiple sites on the protein to which the polyclonal antibodies bind and truncating either
end of the protein reduces the total binding sites available. Overall, this suggests 3936
possesses distributed epitopes across the C-terminal domain of MgpB. 3936 bound
tightest to fragment 1, or the full 4a domain, with a Kd close to 1pM (Figure 4). Mutation
R80A also decreased on-rates for 3936, destabilizing binding as might be expected for
long-range electrostatic attraction.
Alternatively for 3935, smaller domains bound with increased on-rates which may
indicate binding concentrated to the central region of the C-terminal domain. This region
was conserved in all truncations, unlike flanking regions. 3935 preferentially bound to the
C-terminal half of 4a-2a (fragment 3) with a Kd close to 5pM (Figure 5). Mutation R80A
(R1236A relative to entire MgpB protein) decreased off-rates for 3935, stabilizing the
interaction. We hypothesize that this arginine’s positive charge (located in the center,
near the N-terminal half of the domain) destabilizes the bound antibody-antigen complex
due to positive charges in the antigen’s epitope.
All experiments exploring effects of truncation and temperature on kinetic
signatures of polyclonal antibodies were completed with the antigen bound to the chip. A
set of experiments coupling the antibody to the chip with the antigen as analyte showed a
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difference in binding signatures. We expected to see enhanced binding due to the avidity
effect when the antigen is coupled to the chip relative to when the antibody is coupled.

Figure 6: Attaching the antibody rather than the antigen to the chip results in binding
changes that are consistent with the avidity effect
Kon/Koff plot for the 3936 and 4673 (anti-MgpB-B) kinetic signatures measured via SPR and evaluated on BIAeval.
Green arrow shows differencing of binding patterns between recombinant protein on chip and antibody on chip
(“flipped” chip).

Once the antibody was coupled to the chip (creating a “flipped chip”) and a
recombinant protein was used as an analyte, on-rates increased slightly, and off-rates
increased significantly compared to previous rates with the antigen coupled to the chip.
For all 3 flipped chips, Kd decreased by ~1-2 orders of magnitude with an antibody chip,
consistent with increased avidity (Figure 6). When an antigen is attached to a surface, we
expect the avidity effect to enhance binding of the antibody analyte flowing over the
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surface as it is bivalent, resulting in a lower Kd relative to when the antibody is instead
coupled to the chip.

Figure 7: MgpB-4a antibody Kd affinity
Recombinant proteins 4a-3,4, and 5, with truncated N, C, or both termini shown above with length
and size relative to fragment 4a-1. Fragment 4a-1 refers to full sequence + transmembrane region.
His tags on beginning and end of fragments. 3935, on bottom, is more specific and binds best to Cterminal recombinant protein. 3936, on top, is less specific and binds best to longer proteins. 4a2a has a point mutation from Arg-Ala at R80A (R1263A), not shown above. Smaller Kd values in
green, increasing Kd in yellow, and largest Kd in orange. Decreasing Kd is indicative of tighter
binding and greater affinity.

Overall, both antibodies bind tightly, but with distinct kinetic signatures and
distinct specificities to truncated domains despite similar experimental origins (Figure 7).
The 3936 antibody sample binds more peptides, consistent with a broader interaction in
which epitopes are distributed throughout the 4a domain. The 3935 antibody sample
preferentially binds truncated peptides containing C-terminal regions rather than Nterminal regions, indicating epitopes in the C-terminal half of the domain.
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Conclusion
Mapping the kinetic signatures of these rabbit polyclonal antibodies establishes
groundwork for understanding how Mycoplasma genitalium avoids the immune response
in vivo. Our findings suggest the two polyclonal antibody sera have differing targets on
the adhesin protein and range in their distribution of epitopes. Comparing binding
signatures to disease severity and longevity can help map what antibody epitopes and
distributions are effective in clearing infection and which are not. Future work involving
mapping human antibody epitopes to MgpB-4a or other immunogenic regions of the
MgpB adhesin protein can aid in the process of assisting the natural immune response
and creating effective strategies that can target the bacteria in vivo. We also hope to
repeat this research similarly using primate and human sera or other recombinant proteins
designed from the adhesin protein MgpC.
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Appendix on Faith and Science
As a Christian scholar, the intersection between my faith and passion for science
is dynamic and closely intertwined. As Francis Collins gracefully explains, “the God of
the Bible is also the God of the genome. He can be worshipped in the cathedral or in the
laboratory” (Collins 78). My own worship takes place intellectually; as a person focused
on the accumulation of knowledge and reasoning, my appreciation for God’s creation is
found within the natural laws that He has given to us to explore. This understanding of
my own personal strengths and my strong background within the Nazarene church have
helped me view a Christian scholar as one who views God as the truth behind all things,
even science.
Growing up in a Nazarene church in Olathe, Kansas provided me with many
wonderful benefits to understanding Christianity, but also introduced obstacles for
engaging in outside cultures. The Nazarene church places heavy emphasis on the value of
“reason, experience, sanctification, and freedom” (Hughes 346). While the community is
an important aspect of these tenants of holiness, individual journeys are stressed, and
each walk of faith is seen as a personal experience. To understand fully the culture within
the Nazarene church, recognition of its past is important. After WWI, an increase in a
counter-culture movement spread throughout all Nazarene churches as isolation from the
temptation of the world was equivalent to moral integrity. Legalism, intolerance, and
quarantine were promoted throughout the church across the nation. A “Christ against
culture” community was fostered, prompting many to attempt to protect themselves from
the temptations of people not like them (Hughes 351). College Church of the Nazarene
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in Olathe has echoes of these legalistic sentiments still found in the congregation,
specifically among older generations who were raised within its boundaries. While the
church is full of loving, God-fearing people, these intense rules of self-restraint can feel
restrictive to many and the church has recently been declining in numbers. Modernization
is re-shaping the church in many ways, but a balance of understanding and growing with
the world without the danger of secularism is still being molded.
New movements of “sanctification as a journey” and the revitalization of the
community are spreading within the Nazarene church, aligning to the time I was growing
up in CCN (Hughes 347). I still have recognized many of the legalistic tendencies that
prevail within my own background and are continuously growing and shaping this area of
my life. As “Christian faith constantly becomes enmeshes with cultural forces”, my own
church’s culture shaped my faith into many great things and many things that do not
reflect the glory of God (Marsden 100). As a science-driven person, the strict adherence
to rules was an easier way for me to live a life of faith and I was comfortable living inside
the Nazarene church “bubble”. However, moving to Seattle has shown me that a faithful
life also takes passion and deep love for others, not just an understanding of how to live
with self-restraint. Jesus was full of intensity for loving all people and a life without sin –
not the following of a set of rules. I appreciate the value my church has given me in
following the bible, but I have had to develop ways to interact with the world outside the
church on my own and learn that this adventuring out of the church’s walls is inherent to
a strong Christian faith.
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The Nazarene church still continues to hold reason in high regard, specifically
promoting the ideas of a higher education after high school. As shown, this can result in
authoritarian-like regulations, but also results in the fostering of intellect within the
community. Science, in general, is not feared by the Nazarene church but misunderstood;
as many in older generations have told me, they do not “believe” in evolution simply
because they do not understand it fully but do not think it is anti-Christian. Because of
this appraisal of science within my community, my enjoyment of investigation and
exploration in my science classes was always met with positivity. As a woman, many
encouraged me even further to enter the STEM fields as they believed it would be great
for gender equality; the Nazarene church, while still needing more gender reform, was
one of the first denominations to promote the ideas of women pastors. At one point in
high school, I attended a sermon interviewing leading scientists on new interpretations of
the creation story in tandem with evolution alongside those with a young earth
creationism background. This promoted my individual desire to be a scientist, while also
showing to me that the church and science belong in conversation and debate together;
one does not negate the necessity for the other. I think I owe much of my appreciation for
science to CCN and am forever grateful for the fostering of intellectual growth that took
place there.
Growing up as a quiet, intellectually-driven girl I have always tried to understand
how the gifts of scientific investigation could be used to help others, as a part of me
thought I could never do anything for the glory of God like the missionaries did. While
my church never disregarded my scientific desires, I always felt slightly guilty about my
desire to work in science rather than going out to preach the word of God. After learning
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more about my strengths throughout high school and realizing that God can use them to
help others medically, I have always felt confident in my decision to pursue a higher
education and research in the war against cancer. As Paul Farmer puts it, “I feel most
alive… when I'm helping people” (Kidder 57). Paul Farmer is a perfect example of using
the strengths God has given to bring light back into the world. While I may never be a
doctor who travels around the world helping others or a missionary gifted with eloquent
speech, I can do my own part to make God’s will a reality. None of these testaments to
God’s will are more holy than the other; I have learned my work is just as important.
Within cancer research, I’ve always had a strong personal connection to my work
outside of my love for scientific exploration. After losing my mother to lung cancer at the
age of 13, I have always desired to rid the world of the disease completely. I have always
strongly argued against the ideas of “everything happens because God wills it to be”,
instead choosing to believe that God uses us within the circumstances of the fallen world
to bring light back. God can work despite the suffering of the world, but he does not will
it so. Because of this, I have always believed my calling was to work within cancer
research because God was able to spark a fire for my passion despite a terrible tragedy.
My honors project participates in the understanding of a disease linked to an increase in
susceptibility to cancer, reflecting my long-term desires to work in this field to do my
own part of healing this broken world.
As a person of faith, I am able to use the gifts God has given me to improve the
world around me. These gifts, to many, seem antithetical to faith but are actually complex
and intertwined. My journey growing up within the Nazarene church and suffering
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through grief has provided me with the opportunity to be a Christian scholar within
cancer research. My academic work is a way in which I can worship God as He is the
truth behind all things, including scientific investigations. A relationship with God, to me,
involves an analysis of how one works best to bring God’s glory into the world and
allowing this understanding of self to be a way in which God can be truly worshiped.
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